ZYBERNO
Stock Report
Updated Sep 1, 2026

CHARLIE’S HOLDINGS, INC. (CHUC)

Healthcare • OTC

$0.22

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
20.0/100
POOR BUSINESS
CHARLIE’S HOLDINGS, INC. (CHUC) scores 20/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-60.7%)
Debt-to-Equity (Solvency Risk):AVERAGE (0.85x)
Operating Margin (Operational Efficiency):CRITICAL (-10.8%)
Return on Capital (Capital Efficiency):CRITICAL (-20.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

CHARLIE’S HOLDINGS, INC. (CHUC) stock report — Zyberno Score 20/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, CHUC generated -$783.00K in Owner Earnings. Reinvestment rate: 0.8%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.22
Market Cap:$60.34M

Valuation Multiples (4)

P/B Ratio:19.25x
P/S Ratio:2.45x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$66.94M

Price Action & Momentum (2)

B. Profitability Assessment

Return Metrics (5)

ROA:-15.7%
Reinvestment Rate:0.8%
Fundamental Growth Rate (g):-0.2%

Margin Analysis (3)

Operating Margin Ttm:-10.8%
Net Margin Ttm:-7.9%
Ebitda Margin:-10.7%

TTM Performance (2)

Operating Margin Ttm:-10.8%
Net Margin Ttm:-7.9%

Yield Metrics (2)

Earnings Yield:$8.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:100.0%
Latest Earnings Filed:2026-04-01

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):0.2%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):78.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.65x
Quick Ratio:0.40x
Cash Ratio:0.07x

Leverage Analysis (3)

Debt To Equity Ttm:0.85x
Debt-to-Equity Ratio:0.85x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-7.99x
Times Interest Earned:-7.99

Capital Structure (4)

Working Capital:4,742,000.00
Cash And Cash Equivalents:527,000.00
Long Term Debt:$263.00K
Net Debt:$6.60M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $24.67M
Linear Growth: 15.0%
📊 Click to view full CHUC Revenue analysis & methodology →
Cost Of Revenue Ttm:$15.26M

Profitability Breakdown (2)

$5.66M-$2.67M

Bottom Line Performance (3)

Net income TTM: -$1.96M
Linear Growth: 78.8%
📊 Click to view full CHUC Net Income analysis & methodology →
Income Before Tax:$3.30M
Ebitda Ttm:-2,639,000.00

Operating Expenses (5)

Operating Expenses:12,327,000.00
R And D Expense:0.00
Sga Expense:7,490,000.00
Income Tax Expense:$426.00K
Interest Expense:271,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:197.0%
Ebitda Margin:-10.7%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$12.79M
Current Assets:$11.99M
Ppe Net:1,206,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:9,657,000.00
Current Liabilities:7,244,000.00
Long Term Debt:$263.00K
Short Term Debt:$6.87M

Equity & Capital (3)

Equity:$3.14M
Retained Earnings:-$10.91M
Common Stock:500,000,000.00

Working Capital Items (3)

Accounts Receivable:452,000.00
Inventory:9,075,000.00
Accounts Payable:3,684,000.00

Special Items (2)

Contract Liabilities:128,000.00
Stock Based Compensation:25,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$6.47M-$783.00K

Investment Activities (2)

Investing Cash Flow:$0.00
Capital Expenditures Ttm:0.00

Financing Activities (3)

Financing Cash Flow:$425.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:32,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.01
$0.02
Earnings Per Share Ttm:-$0.01

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.09
Operating Cash Flow Per Share:-$0.02

Book Value & Capital (2)

Book Value Per Share:$0.01
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.98x
Working Capital Turnover Ttm:5.20x

Receivables Management (2)

Receivables Turnover Ttm:54.58x
Days Sales Outstanding Ttm:6.69

Inventory Management (2)

Inventory Turnover Ttm:1.68x
Days Inventory Outstanding Ttm:217.05

Payables & Cash Cycle (2)

Days Payable Outstanding:88.11
Cash Conversion Cycle:135.62
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:70.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$783.00K

Damodaran Growth Analysis (2)

Reinvestment Rate:0.8%
Fundamental Growth Rate (g):-0.2%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):0.2%
Net Income Growth Rate (Linear):78.8%

Other Growth Rates (1)

Book Value Growth Rate (Linear):14.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:CHUC
Company Name:CHARLIE’S HOLDINGS, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:274.07M
Shares Outstanding Basic:274.07M
Shares Outstanding Diluted:274.07M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 00:21:27 UTC
Data Timestamp:2026-08-20T05:13:34.010263
Scroll to Top